ABSTRACT
INTRODUCTION
Oxidative stress is an important component of many serious diseases [Liu Z, Zhou T, Ziegler AC, 2017; Bjørklund, G., Chirumbolo, S., 2016], and it also plays a role in the process of ageing [Bonomini, F., Rodella, L.F., Rezzani, R, 2015] . It has been proven that the imbalance of free radical processes (FRP) with the predominance of one of its components (oxidative stress) leads to accumulation of pathological genetic aberrations [Wang D, Feng JF, Yuan GY et al. 2017; Vijayalakshmi, P., Geetha, C.S., Mohanan, P.V., 2013] and provokes inflammation [8] [9] and disorders of different organs and body system functioning [ There is no unified approach to the use of FRP parameters, as prognosis markers, and assessing the feasibility and effectiveness of conducting various types of corrective therapy [Chamorro Á, Dirnagl U, Urra X, 2016]. Stroke is the leading cause of disability in the population and the second cause of mortality in the world [Strong, K., Mathers, C., Bonita, R., 2007] . This prevalence makes stroke the most important problem not only for clinical angioneurology but also as a key social problem, which requires the development of maximally effective treatment methods, based on a comprehensive study of pathogenesis aspects.
The aim of this scientific work is to develop a pathophysiological-ly based strategy for treating patients with stroke, based on studying the regularities of FRP course.
MATERIALS AND METHODS
During the study, we conducted a prospective clinicalinstrumental study, which included 383 patients with acute stroke verified by tomography (CT/MRI). In 302 (78.9%) cases, patients had ischaemic stroke (IS), and in 81 (21.1%) cases patients had haemorrhagic stroke (HS). In addition to stroke, 96% of patients had other cardiovascular disease diagnoses, which indicate a high level of vascular comorbidity. The distribution of patients by sex, age, nature and severity of disease is presented in Table 1 . From the table below, it can be seen that HS is a significantly more serious disease than IS.
All patients were hospitalized in the intensive care unit and received complex therapy. When included in the study, patients were divided into two groups: 106 patients received standard therapy, and 277 patients additionally received EC therapy; Ascorbic Acid (AA) -97 (32.1%) patients with IS and 23 (28.4%) patients with HS; Cytoflavin -67 (22.2%) patients with IS and 32 (39.5%) patients with HS; Reamberin -9 (3.0%) patients with IS; Ethylmethyl hydroxypiperidine succinate -29 (9.6%) patients with IS and 11 (13.6%) patients with HS. A combination of two or more energy-correctors was provided to 52 (17.2%) patients with IS and 14 (17.3%) with HS. Patient groups were comparable at the time of hospitalization ( Table 2 ).
All patients underwent clinical and instrumental monitoring in dynamics (until day 21 of hospitalization), which included the study of anamnesis and complaints, clinical somatic monitoring with daily monitoring of blood pressure, heart rate, respiratory rate and body temperature. Neurological status, which includes the consciousness disorder level and motor deficiency, was estimated in detail according to Glasgow Coma Scale (GCS), NIH, the Bartel social adaptation index and the Rankin modified scale. MRT/CT scan of the brain was conducted on all patients during the first hours after hospitalization; thereafter, 34 patients with IS additionally underwent CT/MRT in dynamics; on the 1 st , 5 th and 20 th day in T1, T2 and Flair regimens, respectively. The data on blood and urine analysis, biochemical analysis, coagulograms and the acid-base state of arterial and venous blood were studied in dynamics. Additionally, we also examined the FRP in blood plasma in dynamics. FRP were studied in terms of generation of active oxygen forms (GAOF) by: leukocytes, the indicators of basal chemiluminescence intensity (CLIb) and zymosan-stimulated chemiluminescence intensity (CLIs), the activity coefficient (AC), spontaneous chemiluminescence (SpCL) and hydrogen peroxide-induced chemiluminescence (IndCL) of secondary plasma, antiperoxide plasma activity (APA), and by-products of lipid peroxidation (LPO), the main component of which, is malondialdehyde (MDA). The values studied in 33 cases of healthy people and donors were taken as the normal index for FRP.
The statistical processing of data was carried out using the SPSS 17.0 and Statistica 6.0 programmes with implementation of standard parametric and nonparametric criteria for assessing significant differences. The differences were considered to be significant at p < 0.05. The descriptive statistics of qualitative parameters are presented in the form of frequencies (abs, %), while the quantitative parameters are presented, in the form of the median (Me) and average ± standard deviation; these parameters include the lower and upper quartile, in case a parameter had a far non-normal distribution function. To compare two independent nonparametric samples, we used the Mann-Whitney test, while for multiple comparisons we used the Kruskal-Wallis test. To compare two dependent nonparametric samples, we used the Wilcoxon signedrank test, and for the multiple comparisons we used the Friedman test. The qualitative variables were compared using the χ 2 test (Pearson's chi-squared test, for the analysis of contingency tables). The stratification of obtained results was carried out by multifactor analysis, the basis of which was the correlation matrix (Pearson and Spearman methods). To build this matrix, we determined the characteristic values and corresponding vectors with correlation coefficients r > 0.2; p < 0.05. To determine important factors, we used the principal component method. The number of counted complexes was determined by means of a point chart of normalized stress, which estimates the total weight of variables included in the complex. To select indicators with a high factor load, we used the Varimax orthogonal rotation method. The prognostic modelling was carried out using discriminant analysis and binary logistic regression. Differences were considered to be significant, when p < 0.05.
RESULTS
Positive significant imbalance of FRP was detected on the 1 st day of hospitalization of patients with stroke; however, the degree of severity and the direction of this imbalance varied (Table 3 ). It was established that among the patients with acute IS, the imbalance of FRP mainly affects the peroxide-lipid component markers in the form of a reliable increase in the MDA indicators average of 1.27 times (p < 0.01), SpCL -1.05 times (p < 0.05) and IndCL -1.23 times (p < 0.001). The level of APA among patients with IS was reliably (p < 0.05) reduced on average 1.07 times. In contradistinction from patients with IS, when hospitalized, patients with HS were diagnosed with an increase in oxygen markers: CLIb -1.27 times (p < 0.01) and CLIs -1.42 times (p < 0.01). At the same time, patients with HS had a marked imbalance and lipid components of FRP in the form of a significant increase in the level of MDA by 1.36 times (p <0.01), SpCL -1.11 times (p < 0.001) and IndCL -1.32 times (p < 0.001); in the background, a decrease in APA of 1.15 times (p < 0.01) occurred. The comparative analysis of FRP indexes among patients with strokes of a different nature revealed significant differences, mainly in markers of oxygen stages; according to CLIb (p < 0.001), which on average was 45% higher among patients with HS, AC (p < 0.01) was 55% higher among patients with IS, and SpCL index (p < 0.05) was 26% more under HS. As to the other markers, we have noted the tendencies for more pronounced imbalances of all FRP and HS stages, the pathogenesis of which is more multifaceted.
The consolidated mechanism was the aggravation of free radical imbalance, as the condition of the patient became more severe, with the displacement of the disregulation vector into the peroxide-lipid side. Thus, the level of consciousness disorders, as the main clinical criterion of severity, were chosen for the patients with stroke. In the patients with moderate IS, who were admitted into the hospital without signs of altered consciousness, the parameters of the oxygen stages of FRP significantly exceeded the norm: CLIs on average by 1.18 times (p < 0.05) and IndCL -by 1.25 times (p < 0.001). The patients with severe IS, who had a consciousness disorder when hospitalized, were diagnosed with a significant increase in the parameters of On the 1 st day of hospitalization, the inhibition activity in oxygen markers among patients with altered consciousness states were registered. The obtained data prove that the defence-adaptive role of active oxygen forms release, as a stimulant of activity of its own antiradical systems, under conditions of ischaemia, as well as the pathological role of uncontrolled hyperactivation of peroxide-lipid component of FRP (increasing MDA with decreasing APA) in cell destruction, death by apoptosis and necrosis. Similar changes were also typical for patients with HS. The comparative analysis of FRP indexes determined the significance of the MDA-titer increasing with the increase in severity of health conditions among patients with HS.
In the case of various types of stroke, the TBA-RP (MDA) and APA levels were taken as an early marker of scope and severity of damage. The results of FRP index analysis for different scopes of brain damage show a gradual aggravation of FRP imbalance severity with a shift towards peroxide processes alongside a decrease in antiradical systems activity under the increased scope of stroke. Thus, with a small IS scope (less than 10 cm³), significant changes in the free radical status affected the oxygen part of the oxidative stress spectrum (the increase in CLIs and AC), and thereafter a tendency towards an increase in the defensive APA was noted. With an average scope of IS (10-50 cm³), a significant disruption of peroxide lipid markers was observed against the background of APA decrease (p < 0.05), which sharply aggravated with an extensive IS (more than 50 cm³), illustrating the MDA-titer increase on average by 60% and APA depression by 40% (p < 0.05). In the case of an HS of more than 30 cm³, the highest imbalance in both the oxygen and peroxide stages of FRP was noted, which led to the progression of secondary ischaemia.
The analysis of FRP characteristics performed among the patients who were admitted to the hospital at different periods from the moment of first appearance of clinical symptoms made it possible to reveal the patterns of free radical imbalance development in the absence of drug correction, as staying at home, the patients did not receive adequate therapy. Mostly, the FRP imbalance was expressed among the patients hospitalized on the 2 nd -3 rd day of the disease. At the same time, a gradual change in free radical reactions from oxygen to peroxide lipid in the form of MDA growth was noted against the background of APA decrease with formation of a vicious circle initiated by active oxygen forms and enhanced LPO, i.e., tissue destruction.
The next stage of our study was the differentiation of patients into subgroups with benign (discharged from inpatient department, n = 305, 79.6%) and adverse outcomes (hospital mortality, n = 78, 20.4%, including 48 (15.9%) with IS and 30 (37.0%) with HS). The correlation analysis helped us to determine that the adverse stroke outcome was associated with a high level of neurological insufficiency (according to the NIH scale in dynamics), functional insufficiency (according to Rankin and Bartel scales), depressed level of consciousness, large disease focus (more than 37 cm 3 ), coexisting somatic pathology (CHD, cardiosclerosis, body-weight index increase > 30.5 kg/m 2 ), high diastolic blood pressure figures (> 95 mm Hg), heart rate (> 85/ min), and high respiratory rate (> 20/min) at the time of hospitalization and with the prevalence of complications (pneumonia, stress-protective ulcers of digestive haemorrhage (DH), and venous thromboembolism). Standard laboratory markers examined at the time of hospitalization of patients with stroke were significantly (p < 0.05) correlated with death and are given below in Table 4 . The obtained data allowed conducting an interval analysis of these indicators with the following definition of threshold values and the boundaries of low and high risks of death. A comparative analysis of FRP dynamics among patients with stroke of different genesis who received no EC/ AO revealed a marked imbalance of both oxygen and lipid FRP markers throughout the whole period of in-patient follow-up. In the 2 nd -3 rd week, when diurnal infusions were replaced by the use of tablets, the tendency towards activation of FRP had been noted. Table 5 . Prognosis of mortality risk in terms of FRP among patients with stroke of diff erent natures examined on the 1st day of hospitalization.
times; APA increased in the period from the 1 st to the 10 th day on average by 1.39 times, normalizing by the 5 th day, but during the 10 th -20 th day, we noted the APA tended to decrease by 1.15 times; plasma MDA had increased in the period from the 1 st to the 5 th day by 1.20 times, from the 5 th to the 10 th day -by 1.13 times, and during the 10 th -20 th days -by 1.09 times. The administration of EC/AO therapy from the very 1 st day to patients with stroke of a different genesis led to positive dynamics in FRP. Thus, the pronounced regression of CLIb and CLIs, noticeable already by the 3 rd -5 th day, was maintained up to the 7 th -10 th day, i.e., up to the moment of the last infusion of energy correctors; this result meant that the production of active forms of oxygen subsided, and their concentration decreased, resulting from the interaction with an antioxidant. The second stage in the positive effect of EC therapy was a decrease in the severity of LPO reactions, which was registered by the dynamics of MDA regression and significant growth of APA by the 3 rd -5 th -7 th -10 th day. It should be noted that there was a tendency of FRP activation after the end of EC therapy (by the time of discharge), which indicated the need for longer (more than 10 days) EC/AO therapy.
The use of EC therapy not only contributed to the normalization of FRP parameters but also allowed the improvement of the treatment results. The inclusion of EC/AO therapy into the complex therapy of patients with stroke resulted in a more rapid regression (than in the comparative group) of consciousness disturbances (p < 0.05) as well as focal neurologic symptoms with authentically more significant regression by the time of discharge (p < 0.05). The final stage of the study was the development of a mathematical model for stroke prognosis. To this end, we used discriminant analysis (DA), and with the help of ,several characteristics, an individual could be assigned to one of the given groups. The DA core was the construction of the discriminant function: D = b 1 x 1 +b 2 x 2 +... + b n x n +a, where x 1 and x n were the values of variables that corresponded to the examined cases; a was constant; b 1 -b n were coefficients, which were estimated using DA. During the study, we determined the values of D; it was then possible to carry out the division into groups for stroke prognosis with a maximum accuracy.
To form the prognosis model of FRP parameters, we initially used all studied variables: CLIb, CLIs, AC, SpCL, IndCL, APA and MDA. Later, their number was reduced to two (APA, MDA) without critical loss of prognosis significance. Thus, according to the DA results, when D ≥ 0.55, the patient fell into the 'adverse outcome' group, and when D ≤ -0.3, the patient fell into the 'benign outcome' group. The prognosis accuracy was 68.6% (p < 0.05). However, the obtained accuracy did not satisfy us. Therefore, we later conducted a multifactor analysis of all clinical laboratory parameters assessed in dynamics among patients with stroke. The purpose of this analysis, first, was to detect the persistent correlations between variables, mainly for the further construction of an accurate prognostic model of disease outcome. The initial array of observations was formed on the basis of data from 383 patients with cerebral stroke. At the first step of the factor analysis procedure, we selected 119 indicators (including dynamics up to the 20 th day of observation) that had a proven or presumed influence on the course and outcome of stroke, and then we standardized the set values of variables (z-transformation). Based on the analysis of the total variance, we received 191 factors, including 79 factors excelling in strength;, the indexes were grouped by their strengths of influence on the general picture of indicator variability and explained 95.18% of the total variance. For further exclusion criteria, we used the Cattell scree test, and as a result, we determined 4 HS. After performing 8 rotations by the Varamax method, the significant factors were united into the main components in descending order, which allowed for choosing and reducing them in the future.
Significant multiple correlation coefficients confirmed the descriptiveness and prognosis value of selected clinical and biochemical parameters complemented by the parameters of instrumental methods. Based on the multivariate analysis results, for our further DA and for the future development of an IS prognosis model, we selected the 22 most significant factors studied during the hospitalization of patients and reflected them in the main components, which characterized the outcome (death or discharge):
CLIb, CLIs, AC, APA and MDA; consciousness level by Glasgow Coma Scale (GCS); Bartel index; modified Rankin scale score; NIH; blood pressure; heart rate; white blood cell count; lymphocyte, glucose, thrombocytes, creatinine, urea, potassium, sodium and fibrinogen levels; and ALT, AST, LDH, PTI, INR and prothrombin time. The further step-to-step minimization of their number (up to 5 major factors) allowed for performing DA with reliable accuracy and formulating a mathematical model of ischaemic stroke outcome. 
D=

CONCLUSION
The performed study has shown that in the case of stroke of different natures, accompanied by syndromes of tissue ischaemia, hypoxia, and local and systemic inflammatory reactions, we can observe the same sequence in the development of oxygen imbalance and lipid stages of FRP; we can further observe the rate of unfolding of these syndromes, and which convey the dynamics of clinical and standard laboratory indicators. The earliest markers of FRP imbalance severity are the CLIs and CLIb, which characterize the imbalance of the FRP oxygen component. In cases of increasing ischaemia, the greatest imbalance is revealed by the levels of parameters reflecting the stage of lipid peroxidation (decrease of APA and growth of MDA).
Among the patients with ischaemic stroke, the imbalance markers of FRP lipid phase were as follows: MDA increased by 1.27 times, and APA decreased by 1.07 times. In cases of haemorrhagic stroke, CLIb increased by 1.27 times, CLIs -by 1.42 times, and MDA -by 1.36 times; however, APA decreased by 1.15 times. The levels of critical MDA values were as follows: 6.39 μmol/l -in IS; 5.41 μmol/l -in HS.
The study of FRP index dynamics, among patients with stroke of different genesis who received no EC therapy, has shown a marked imbalance in both the oxygen and lipid stages throughout the whole period of in-patient follow-up, with a tendency to activate FRP by the time of discharge. The early inclusion of AC/AO therapy into the complex treatment of patients with critical states of various natures and severity promotes the activation of consciousness, which advances the comparison group, the regression of neurological insufficiency by means of reducing the cerebral ischaemia zone, the reduction of disability with a change in its structure by means of decrease of severe, and the increase of good functional outcome.
The established digital boundaries of risk of adverse outcomes for various laboratory indicators became a key result of the study, making it possible to recommend the use of these indicators, as early prognostic markers of stroke course and outcomesto and to carry out the early diagnosis and prognosis of stroke. The multifactor analysis of more than 700 criteria (indicators evaluated in dynamics among patients with stroke), discriminant analysis, logistic regression and mathematical modelling allowed the identification of the formula that includes only 5 factors, the assessment of which, on the 1 st day of hospitalization, makes it possible to predict with a high degree of accuracy (more than 88%) the outcome of a stroke. These results gives us an opportunity to timely optimize stroke therapy and to improve treatment results.
